Needle-free GLP-1s: approved pills and compounded tablets, priced
As of November 20, 2026, the FDA-approved needle-free GLP-1s cost $149 to $299 a month self-pay: the Wegovy pill ($149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg through NovoCare) and Foundayo (from $149 through LillyDirect). Compounded alternatives, which are not FDA-approved, include NexLife’s sublingual tablets at $229 tirzepatide or $199 semaglutide month to month.
Released · Last reviewed · how we verify
Needle-free options and their prices
| Option | Medication and status | Price | Read |
|---|---|---|---|
| Wegovy pill (NovoCare) | semaglutide, FDA-approved | $149 / $199 / $299 by dose | read November 20, 2026 |
| Foundayo (LillyDirect) | orforglipron, FDA-approved | from $149; 2.5 and 5.5 mg temporarily reduced through December 31, 2026 | ladder carried from October 15; $149 start confirmed by Lilly November 6, 2026 |
| NexLife sublingual ODT | compounded tirzepatide, not FDA-approved | $229 month to month, $199 a month on 12 months | read November 20, 2026 |
| NexLife sublingual ODT | compounded semaglutide, not FDA-approved | $199 month to month, $165 a month on 12 months | read November 20, 2026 |
| Mochi Health | compounded semaglutide pill, not FDA-approved | from $62 plus membership ($79, or $49 on 12 months) | read November 20, 2026 |
| Henry Meds | oral compounded tirzepatide, not FDA-approved | $1,047 for a 3-month supply ($891 paid in full) | legal price page dated December 3, 2025; read November 20, 2026 |
What the evidence covers
The Wegovy pill and Foundayo were tested in phase 3 trials and approved by FDA; their labels set out absorption and dosing. Compounded tablets, drops and dissolving tablets have no published trials and no FDA review, and how much drug is absorbed under the tongue is not established. NexLife’s ODT pages say prescriptions may be filled by 503A pharmacies or 503B outsourcing facilities; this site has not verified that claim. A clinician should decide whether any oral option suits you.
Price check against injections
Compounded injections cost less per month at most programs: NexLife’s injectable tirzepatide is $129 against $229 for its tablets. Brand injections bought direct cost more than the pills at the same company: Wegovy pens are $349 against $149–$299 for the pill.
Frequently asked
What is the cheapest needle-free GLP-1?
As of November 20, 2026, the FDA-approved needle-free GLP-1s cost $149 to $299 a month self-pay: the Wegovy pill ($149 at 1.5 mg, $199 at 4 mg, $299 at 9 and 25 mg through NovoCare) and Foundayo (from $149 through LillyDirect). Compounded alternatives, which are not FDA-approved, include NexLife’s sublingual tablets at $229 tirzepatide or $199 semaglutide month to month.
Are compounded GLP-1 tablets FDA-approved?
No. Compounded tirzepatide or semaglutide tablets, drops and dissolving tablets are not FDA-approved and have no published trials. The FDA-approved oral GLP-1s for weight loss are the Wegovy pill (semaglutide) and Foundayo (orforglipron).
Sources
- NovoCare Pharmacy: Wegovy self-pay prices (read November 20, 2026)
- Lilly and Hims & Hers joint release (November 6, 2026; read November 20, 2026)
- Wegovy (semaglutide) prescribing information on DailyMed (read November 20, 2026)
- NexLife sublingual tirzepatide ODT page (read November 20, 2026)
- NexLife sublingual semaglutide ODT page (read November 20, 2026)
- Mochi Health FAQ (read November 20, 2026)